摘要
原发性高血压患者合并糖尿病概率极高,两种疾病具有较高的共患性,合并症患者出现心血管疾病风险也远高于单一高血压患者,因此临床在预防管理高血压患者过程中需要密切关注监测血糖指标,及时发现并干预危险因素,改善患者预后质量。随着临床血糖监测方法及技术的不断进步,末梢血快速血糖仪(POCT血糖仪)与生化分析仪仍然为临床常用两种技术,但是探讨POCT血糖仪及生化分析仪的临床应用效果及实践应用价值,如何合理应用血糖检测方法已经成为临床重要研究课题,并得到了广泛关注。因此,对POCT血糖仪与生化分析仪在当前高血压患者血糖检测的应用进展及对比研究进行分析有着重要意义。
The probability of primary hypertension patients with diabetes is very high,the two diseases have high comorbidity,and the risk of cardiovascular disease in patients with comorbidity is also much higher than that in patients with single hypertension.Therefore,in the process of clinical prevention and management of patients with hypertension,we need to pay close attention to monitoring blood glucose indicators,timely discover and intervene risk factors,and improve the prognosis quality of patients.With the continuous progress of clinical blood glucose monitoring methods and technologies,POCT and biochemical analyzer are still commonly used in clinic.However,to explore the clinical application effect and practical application value of POCT and biochemical analysis,how to reasonably apply blood glucose detection methods has become an important clinical research topic,and has been widely concerned.Therefore,it is of great significance to analyze the application progress and comparative study of POCT blood glucose analyzer and biochemical analyzer in the detection of blood glucose in patients with hypertension.
作者
李嘉
LI Jia(Department of Laboratory Medicine,Tianjin Huanghe Hospital,Tianjin 300190)
出处
《中国医疗器械信息》
2021年第18期21-22,182,共3页
China Medical Device Information
关键词
末梢血快速血糖仪
生化分析仪
高血压
血糖
进展
peripheral blood fast blood glucose meter
biochemical analyzer
hypertension
blood glucose
progress
